Abstract

HYPERLIPIDEMIA AS A PREDICTOR FOR EVALUATION OF CARDIOVASCULAR RISK IN CHRONIC KIDNEY DISEASE PATIENTS

Ganji Komali*, Golla Supriya, Ede. Sri Lakshmi, Natta Prathibha and Kantamaneni Padmalatha

.

Abstract

Dyslipidemia is a potential risk factor for to access cardiovascular disease in chronic kidney disease patients. It promotes the identification and treatment of hyperlipidemia as a symptom of endstage renal disease. Different phases of renal impairment are characterized by various qualitative and quantitative alterations, which are linked to the rate of glomerular filtration rate decline. Elevation of serum lipoproteins like total cholesterol, triglycerides, and low-density lipoprotein and decrease of high-density lipoprotein shortage and their atypical functions in chronic kidney disease patients as the major problem of atherosclerosis. So that studying the lipid profile in renal disease patients is essential to preventing morbidity and death because dyslipidemia, which is quite common in individuals with the condition, causes cardiovascular disease the most common cause of mortality. So strictly monitoring the lipid profiles along with regular hemodialysis and proper medical management will help to prevent various complications and will also improve the quality of life in CKD patients.

Keywords: Dyslipidemia, Cardiovascular, Chronic Kidney Disease, End stage renal disease.